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A B S T R A C T
Mortality rates continue to decline among post-reproductive individuals. This makes understanding long-term physi-
ological responses to stress increasingly important. Allostatic load (AL) was developed to assess detrimental effects on the
soma of responding to multiple stressors over a lifetime. AL arises from developmental experiences, genetic predisposi-
tions, environmental, psychosocial, life style and other stressors. In early life stress responsive systems are initiated that
produce hormones that maintain the soma through continual allostatic responses. Later in life, systems designed to miti-
gate stressors may fail or be compromised, promoting unwanted somatic changes and dysregulation. This places a load
on the regulatory system that impedes day-to-day stress responses, predisposing to cellular damage and degenerative
diseases. Here we review 44 peer-reviewed 2005–2010 publications reportedly examining relationships between AL and
risk factors, chronic diseases, morbidity and mortality in samples of elderly adults. The sum of results suggests that AL
does assess aspects of physiological dysregulation and somatic decline, predicts detrimental age-related declines, and is
associated with negative sociocultural attributes and psychological outcomes. Such consistent results and wide applica-
tion of AL, while it is still being modeled and re-interpreted, suggest its perceived usefulness as a research and clinical
tool. AL provides a possible biomarker of senescence, assessing it over the life span will aid in predicting future negative
health outcomes.
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Introduction
In modern populations, individuals are surviving into
old age at unprecedented rates. For example, over the 20th
century, life expectancies increased around the world as
0.076% of men and 0.338% of women attained 100 years1.
By 2007, mean life expectancy was 77.9 years in the USA,
82.7 years in Japan, 82.2 years in Hong Kong, 81.8 years
in Iceland, and 81.8 years in Switzerland2. As life expec-
tancy increases and mortality rates decline among
post-reproductive individuals, understanding processes
of senescence leading to morbidity and mortality becomes
increasingly important.
Exposures to stressors over the lifespan likely mediate
aspects of senescent decline. Stressors such as work and
home environments, social and community relationships,
diet, exercise, physiological and psychological responses,
lifestyle, and socioeconomic status alter physiological func-
tion3. Two concepts, allostasis and allostatic load, have
been developed to model and assess effects of stressors on
human well-being. Allostasis originated as a term com-
paring and contrasting resting and active states within
the cardiovascular system and as an elaboration of the
more static concept of homeostasis4. Allostasis refers to
the soma’s ability to respond with continuous change to
maintain a dynamic equilibrium in response to stressors
and external stimuli3. Physiologically, allostasis repre-
sents the soma’s ability to change while maintaining
overall somatic stability4,5. It describes the constantly
changing functional relationships among chemical and
hormonal responses activated and deactivated as our
somas respond to stress-related signals. As an example,
the hypothalamic-pituitary-adrenal (HPA) axis releases
cortisol in response to perceived stress. In normal func-
tion, cortisol decreases to basal levels as the specific
stress is attenuated6. Efficient allostasis is described as
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facile adaptation, including a quick response to stress and
a rapid return to baseline following elimination of the
stressor7. However, over time, allostasis becomes impair-
ed by exaggerated or delayed reactivity peaks and a ten-
dency to sluggish recoveries5,7,8. Wear and tear accumu-
late as the soma adapts to multiple and varying environ-
ments, resulting in allostatic load5,9,10. Returning to the
example of cortisol, as allostasis becomes sluggish, exag-
gerated, or delayed cortisol may not be removed from the
blood as rapidly. Cortisol has both cardiotoxic and neuro-
toxic effects; continued exposure to high titers may dam-
age systemic physiology. Similar to the effects of cortisol,
exposure to other factors such as adrenaline, noradre-
naline, obesity, C-reactive protein, interleukins, hyper-
tension, or hyperlipidemia, may lead to progressive phys-
iological damage, functional loss, and increased allostatic
load.
Stress
Multiple definitions of stress pervade the literature,
suggesting variable reported associations of stress with
morbid and mortal outcomes may reflect definitional
disagreement3–7,9–12. Regardless of how stress is defined, it
can be assessed and measured using a variety of meth-
ods, from self-reports and questionnaires to assessments
of blood pressure, hormones and stress testing3–5,9,10,12,13.
Stress is likely more damaging to elders than generally
reported13:295. Many chronic degenerative diseases affect-
ing elders may be related to physiological and psycho-
social mediated stress. The somatic impact of such stress
likely is influenced by personal experiences, genetics,
and behaviors13.
Stressors are everywhere in modern human life. Other
people and social relationships are among the most pro-
minent daily stressors; these may affect us at work, school,
or home and include spouses and children10–13. Stressors
also extend to care-giving, emotional support, financial
situations, mental anxiety associated with performance,
mental health issues (e.g. depression, isolation), public
speaking, and job performance12–17. Our environments,
including climate, radiation, temperature, hypoxia, diet,
and infectious and parasitic agents all produce physiolog-
ical and mental stress. Our somas are constantly exposed
to oxidative stress, poor/under/malnutrition, stress re-
sponsive hormones, chronic and acute illnesses, immune
responses to infectious diseases, injuries, and hun-
ger3–5,7–10,12–17.
Stress and anxiety secondary to multiple stressors
may lead to immune and hormonal dysfunctions5,7,9. For
example, during exams (stress) college students have
lower white blood cell counts (response)7,14. Similarly, de-
pression (a stress) is associated with poor immune and
altered endocrine responses, and reduces one’s ability to
sleep7,13. Lack of sleep diminishes the soma’s ability to
repair damage to somatic cells, leading to lack of somatic
recovery, poorer immune function, and increased senes-
cence (response)7. Negative social relationships also acce-
lerate senescence: for example, occupational stress is as-
sociated with increased serum MDA (malondialdehyde),
higher levels of which increase oxidative stress15, a major
promoter of senescence16. Stress produces a physiological
cascade of increasingly poor health and an increasing se-
nescent phenotype.
Allostatic Load
Allostatic load represents a composite assessment of
long-term physiological dysregulation occurring second-
ary to somatic responses to stress. First articulated by
Sterling and Eyer during the 1980s, the conceptualization
of AL has developed continually since the 1990s3–5,9,10,15,17–19.
AL is modeled to assess wear and tear on the soma from
continually responding to multiple stressors. By assess-
ing function across multiple physiological systems, AL is
constructed so as to measure dysregulation believed to
result from somatic stressors10,21.
Primary mediators of AL are hormones produced by
the sympathetic nervous system (SNS), HPA, and other or-
gans. In its original formulation, primary mediators of AL
included: catecholamines (epinephrine, norepinephrine),
cortisol, and dehydroepiandrosterone sulfate (DHEA-s)21
(Table 1). Today, additional hormones and proteins are
being used to assess AL: insulin-like growth factor-1
(IGF-1), interleukin-6 (IL-6), serotonin, fibrinogen, dopa-
mine, C-reactive protein (CRP), creatanine, albumin,
and thrombin17–19. As yet, none have produced signifi-
cantly better models of AL than the original. Inclusion of
different physiological measures when modeling AL sug-
gest that the construct is still being interpreted and re-
fined as research on applying AL proceeds.
Primary stress mediators control a cascade of bioche-
mical and physiological reactions promoting secondary
physiological outcomes. These include elevating systolic
and diastolic blood pressure, total serum cholesterol,
HDL-cholesterol, triglycerides, fasting glucose, and gly-
cosylated hemoglobin, along with increasing aspects of
body habitus such as skin folds, body mass index (BMI)
and waist-to-hip ratio18. Tertiary or disease outcomes of
elevated AL are chronic degenerative diseases: atheroscle-
rosis, cardiovascular diseases, and diabetes mellitus3,16,18,20.
In the near future AL or a construct thereof will provide
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TABLE 1
THE COMPONENTS OF ALLOSTATIC LOAD
Primary Mediators of Stress
Serum dihydroepiandosterone – sulfate
Overnight urinary cortisol, adrenaline, noradrenaline
Secondary Mediators of Stress




After Seeman et al.20.
a useful clinical and research tool for predicting, and
eventually mitigating, secondary and tertiary outcomes.
Loss of allostasis and subsequent increase in allo-
static load likely reflect a number of underlying cellular
senescent processes. Over the past century and a half, se-
nescence has been defined in a variety of ways (e.g.
21–23). Today, general senescence is viewed as a biologi-
cal process characterized by an accumulation of meta-
bolic byproducts leading to cellular dysfunction and a de-
creased probability of reproduction and survival17.
Senescence is an age-independent, individualized, prog-
ressive, multifactorial, deleterious and irreversible cellu-
lar process that leads to an increased probability of death
over time by affecting all organs and physiological sys-
tems22,23. Since Sterling and Eyer introduced allostasis
and AL in 1988, research exploring relationships of AL
with losses of functions, frailty and higher morbidity and
mortality in elders has exploded4. In 2005, Stewart re-
viewed existing research on AL listed in the ISI »Web of
Science« and published between January 2000 and June
200519. In this review, we examine articles reporting on
AL and its correlation with aspects of somatic decline. We
restricted our review to research published between July
2005 and December 2010 and indexed in the ISI »Web of
Science«. As part of discussing these papers we also ex-
plore directions for further application of AL in clinical
and research settings.
Methods
The SCI indexes over 10,000 unique titles from scien-
tific, social science, art, and humanities journals (ISI
Web of Knowledge 2009). The database is updated wee-
kly. Restricting our review to papers published July 2005
to December 2010 prevented overlap with Stewart’s 2006
review18. We review 44 publications indexed with the key
words-allostatic load, senescence, and aging. The major-
ity were analyses of new data (27 of 44; 60%). Of the re-
maining, 13 were reviews and 4 were papers suggesting
improvements to mathematical modeling of AL.
Results
Several points about these papers are salient. First,
many applications of AL do not use the specific 10 physi-
ological measures enumerated by McEwen and Stellar10
and Seeman et al.20. In fact many applications are at-
tempting to either re-model or re-interpret the original
construction. Second, although there is wide consistency
in the way AL is assessed (measuring physiological para-
meters and summing across risk factors in the highest
quartile of risk), there is little consistency in how many
or which aspects of physiology are included. In several
cases, it seems authors went to previous or current re-
search and whatever risk factors were available and con-
structed their own idiosyncratic model of AL. Lack of
consistency due to particularistic operationalization of
AL constructs makes comparing across studies difficult.
These inconsistences are highlighted to some degree in
this review by discussing common and alternative con-
structs of AL and variable types of AL, such as those
based on a single variable (e.g.: cortisol), just neurologi-
cal variation, or past diagnoses of a mental or physical ill-
ness. Additionally, these various constructs of AL have
been associated with a variety of potential outcomes –
chronic diseases, physical activity, cognitive disorders,
post-traumatic stress disorder (PTSD), and depression
or with social support and SES.
Modeling Allostatic Load
Calculating AL
In its original formulation AL was measured by sum-
ming 10 biological variables (see Table 1) for which an in-
dividual falls into the highest risk quartile of each mea-
surement’s distribution10,18,21. This is the upper quartile
for all of McEwen, Seeman and colleagues’ original pri-
mary and secondary mediators, except DHEA-s and HDL
for which the 25th percentile and below is considered the
highest risk quartile3,5,10,15,20,25,27–29. Original counts of
AL are one-tailed and range from 0–10, leading to an AL
of 0–10.
Alternative methods for determining AL
In recent years, several authors have questioned the
validity of this simple procedure (e.g. 7, 28, 30). For one,
physiological reactions to stressful experiences may lead
to either elevated or decreased chemical and hormonal
levels30. For example, both high and low cortisol may in-
crease physiological wear-and-tear31–33. Additionally, sym-
ptoms of conditions such as PTSD are linked to low, not
high, cortisol levels28. Such results suggest future assess-
ments of AL may need to incorporate risks with two-
-tailed criteria30. For example, Seplaki et al. evaluated
different constructs of AL, but their alternative biomar-
kers only moderately influenced predictability of morbid
outcomes17. They conclude that »…count-based summary
measures incorporating risk at both high and low tails
and measures that preserve the continuous properties of
the biological variables are strategies that may yield
stronger predictions of a wider array of health outcomes
than other measures…«18:445.
To compare different estimates of AL, Seplaki et al.
computed AL for an elderly Taiwanese sample combining
between 10 and 16 biomarkers, one- and two-tailed risk
categories, and different percentile cut points (<10% and
>90% as compared to <25% and >75%)17. All AL scores
were then compared to self-reported health, activities of
daily living (ADL), reported mobility, the Centers for Epi-
demiologic Study of Depression Scale (CES-D) score, and
an assessment of temporal orientation. Number of bio-
markers and different percentile cut points only modestly
affected AL’s correlation with proposed dependent out-
comes17. Conversely, AL constructs incorporating risks at
both high and low levels better predicted an array of
health outcomes than did constructs with only unidirec-
R. Leahy and D. E. Crews: Modeling, Applying, and Re-Interpreting Allostatic Load, Coll. Antropol. 36 (2012) 1: 11–22
13
tional risk17. Such two-tailed analyses are becoming in-
creasingly prevalent in published reports (e.g. 23, 34–35).
Karlamangla et al. proposed another alternative meth-
od for scoring AL35. Data were collected on a cohort of
high-functioning 70–79 year-olds from the 1988, 1991,
and 1995 rounds of the MacArthur Successful Aging
Study. Change in AL over time was assessed and used to
predict all-cause mortality over 2.5 and 4.5 years follow-
-up. The ten original primary mediators were evaluated
for each. Next, to account for two-tailed risk as well as
possible non-linear relationships with coronary heart
disease and mortality, Karlamangla et al. added a term
assessing each biomarker’s deviation from the mean35.
These values were weighted according to their independ-
ent associations with 7-year all-cause mortality35. Next, a
bootstrapping technique was used to identify each com-
ponent’s contribution to the AL model; elements not con-
tributing were eliminated35. Among participants with
the same baseline AL, women were less likely to die than
men35. Those with lower baseline AL tended to have a
greater increase in AL over time35. Increases in AL over
2.5 years were predictive of all-cause mortality over the
following 2 years. These results show that even among
high-functioning elders increased AL is associated with
increased risk for mortality35.
While many authors continue to evaluate AL by using
the 10 biomarkers originally proposed by Seeman et al.20,
others have had success utilizing different formulations
of AL. The present review provides evidence that numer-
ous variations of the AL calculation correlate with unde-
sirable outcomes. Because of AL’s intrapersonal and in-
trapopulational specificity, it is formulated solely for the
sample examined and is not comparable among samples.
Critiques of AL
AL has been critiqued as static because it does not ac-
count for intrapersonal stressor reactivity. Individual
temperament influences emotional reactions to stress-
ors. In turn, genetic predispositions, lifestyle choices, so-
cial context, and environment impact physiological res-
ponses to emotions7. For example, an exaggerated
cortisol response to stress seems to be typical in individu-
als with a »…cognitive style characteristic of greater
trait anxiety…«7:14. Those with greater social support
tend toward lower cortisol reactivity to social stressors7.
To tailor AL to individual reactivity, Piazza et al. suggest
participants’ record stressors and associated emotional
reactions in daily diaries and that these data be exam-
ined for correlation with biomarkers34.
Applying Allostatic Load
Allostatic load and chronic disease
Most studies of AL have been conducted on US sam-
ples. However, several authors are attempting to deter-
mine the applicability of AL in non-Western populations
(i.e. 17, 27, 33, 37–40). Crews assessed distributions of
stress using four models of AL combining different physi-
ological measures and their possible associations with sex,
age, and diabetes in a Samoan sample16. Assessed first
were the ten primary mediators proposed by McEwen and
Stellar as well as fasting insulin10. Model 2 eliminated
measures of glycated hemoglobin (HbA1c) and fasting in-
sulin. Model 3 added tricep and subscapular skinfolds,
body mass index (BMI), and relative fat pattern index
measures to Model 1. Model 4 combined Model 1 with
LDLc and measures of triglycerides and fasting glu-
cose16. Diabetes was assessed by a fasting or 2-hour
post-load glucose level at or above 140 mg/dl16. Among
older Samoans, age was poorly correlated with AL, al-
though there was a positive association for women17. For
men, models 3 and 4 were significantly associated with
diabetes. For women, all four models were significantly
associated with diabetes16. Results suggest that regard-
less of the method used for measurement, stress load
composites tend to show predictive value for diabetes
morbidity among women and to some degree among
men, but were not significantly related to chronological
age16.
Allostatic load and physical activity
The association between AL, mobility, and healthy se-
nescence was evaluated utilizing data from NHANES 3
participants. Mobility was assessed by self-reports of dif-
ficulty of walking (none, some, much, or unable). AL was
calculated according to Crimmins et al.40, incorporating
measures of diastolic and systolic blood pressure, HbA1c,
BMI, triglycerides, HDL cholesterol, total cholesterol, al-
bumin, C-reactive protein, fibrinogen, peak respiratory
flow, creatinine clearance, and homocysteine41,42. Con-
trolling for age, sex, race, disability (assessed by ADLs),
and years of education, lower AL was associated signifi-
cantly with higher mobility, suggesting that mobility
plays an important role in healthy aging42.
Based on a sample of elderly but active ballroom danc-
ing participants, Strahler et al.8 suggest no physiological
association between AL and age. Rather, they suggest
physical activity helps individuals maintain a healthier
AL. However, these authors seem to confuse age with se-
nescence. In general, active individuals tend to be health-
ier than their chronologically identical inactive peers.
Strahler et al.’s results support the hypothesis that old but
active individuals experience less senescence and show
lower AL than their less active counterparts8.
AL and cognitive disorders
Individuals suffering bi-polar disorder (BD) may ex-
perience more rapid senescent decline than healthy indi-
viduals39. To assess how BD associates with senescent de-
cline, Cacilhas et al. evaluated AL in 100 Brazilian
outpatients with BD39. AL was not assessed using bio-
markers, but rather responses to the Functioning As-
sessment Short Test (FAST). FAST evaluates disability
using questions about autonomy, work, cognitive functio-
ning, financial issues, and interpersonal relationships39.
Lower FAST scores are associated with greater functio-
nal impairment. BD patients reported significantly more
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impairment than did controls. Cacilhas et al. suggest this
supports their hypothesis that BD accelerates senescent
decline39. However, as AL was not assessed using bio-
markers, their research is difficult to integrate into the
current AL paradigm and illustrates non-traditional con-
structs are being applied without adequate interpretation.
AL and socioeconomic status
Using another non-traditional construct, Kahn and
Pearlin measured AL based on a participant’s past diag-
noses of 5 chronic conditions (cancer, stroke, heart disease,
high blood pressure and diabetes) and 9 common symp-
toms (headaches, back pain, muscle aches, indigestion,
constipation/ diarrhea, incontinence, feelings of weak-
ness, heart palpitations, shortness of breath, and rank-
ing on a depressive symptoms scale)42. They compared
this index to retrospective data on participants’ long-
-term financial hardship. Controlling for current econo-
mic situation, results indicate long-term financial hard-
ship is associated with higher rates of chronic conditions
and symptoms42.
Poverty may have its greatest influence on biological
risk early in life. Life expectancy at age 20 differs mark-
edly by biological risk and poverty status suggesting that
extreme poverty yields higher risk at younger ages34.
Among older individuals, biological risk secondary to
poverty may be mitigated, most likely because higher
risk individuals have died and only less at-risk individu-
als survive34.
AL and PTSD
To ascertain physiological effects of PTSD on women,
Glover et al. assessed AL in a sample of 29–55 year-old
mothers of childhood cancer survivors from California us-
ing the Posttraumatic Stress Diagnostic Scale (PDS)27,43.
Chronic stress and recent stress history were evaluated us-
ing the Life Experience Survey (LES), AL was assessed
using the model originally proposed by Seeman et al.
1997 with one difference; cortisol was counted when a
participant scored in either the lowest or highest 12.5%
of the sample distribution because either low or high
cortisol may be detrimental10,27. Interestingly, mothers
with PTSD showed the highest norepinephrine titers,
but lowest cortisol27. AL significantly correlated with
PTSD symptoms reported on the PDS, showing a dose-
-dependent association. Women with the highest AL ex-
hibited PTSD, those in the middle range of AL scores
showed some PTSD symptoms, while the low AL group
showed no PTSD symptoms27. AL did not correlate sig-
nificantly with traumatic events experienced in the past
as measured by LES scores27. These results demonstrate
the usefulness of AL in middle-aged adult women, while
validating the hypothesis that a composite AL score is a
more effective predictive tool than any single biomarker.
AL and depression
Previously depressed individuals tend to show early
signs of physical decline, suggesting that depression may
accelerate senescence7, 44. Catecholamines and cortisol
likely mediated this effect7. In addition, absence of or low
depression corresponds with higher levels of self-perceiv-
ed health. For example, significant positive association is
seen in polio patients between having a clear purpose in
life and less self-perceived decline in health over time46.
Cho et al. assessed the effect of prior depression on
senescence44. Using an abbreviated version of the CES-D
and two questions about prior depression, senescent de-
cline was assessed at 6 weeks, 1 year, and 2 year follow-
-up using the Chronic Disease Score (CDS) and Physical
Component Summary (PCS) of the 36-Item Short-Form
Health Survey44. After adjusting for age and education,
measured senescence was significantly worse in the de-
pressed sample as compared to a control group44. Over-
time, both CDS and PCS scores declined significantly
more in the prior depression group, independent of cur-
rent depression level45. This suggests that, despite a gen-
eral opinion that once depressive symptoms are control-
led risk for adverse outcomes is reduced, negative effects
of depression endure beyond resolution and predict se-
nescent decline among elders44. Although Cho et al. mea-
sured physical decline using CDS and PCS as proxies,
they suggest that system dysregulation as assessed by AL
is the likely physiological pathway mediating observed
senescent decline44–46. Besides depression, self-percep-
tion may mediate senescent decline. For example, indi-
viduals from high stress environments tend to perceive
themselves as less healthy46. Additionally, individuals
who are better equipped to handle stress may self-select
into higher stress jobs47.
AL and social support
Maselko et al. evaluated the relationship between re-
ligious service attendance and AL using data from the
1988 wave of the MacArthur Successful Aging Study48.
Religious activity was assessed through questionnaires
and confounding with social interactions was controlled
by assessing only attendance at weekly church services48.
AL was assessed according to the original model3,46. Wo-
men with lower AL attended religious services signifi-
cantly more frequently and demonstrated lower epineph-
rine and waist-hip ratio48. However, variability in AL was
not solely due to these two factors48. Among men, no sig-
nificant association between AL and religious activity was
identified. This finding is consistent with other studies
wherein gender differences influenced associations be-
tween religious participation and health48. AL was inde-
pendent of social network/support levels, participants’
subjective religiosity, and congregation48. Analyzing an el-
derly sample, Pruessner et al. reported that cortisol de-
creases as individuals age49. They also show that self-es-
teem is both age- and cortisol-independent in these elders.
Interpreting/Re-Interpreting Allostatic Load
Neuroendocrine allostatic load
Another way of assessing AL is now known as neuro-
endocrine allostatic load (NAL)27,33. Proponents suggest
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that because NAL evaluates only catecholamines, corti-
sol, and DHEA-s it is based on a »…physiologically coher-
ent class of markers representative of the neuroendo-
crine stress response«27,37–39. NAL represents activity in
both the HPA-axis (cortisol and DHEA-s) and SNS-axis
(catecholamines)24. Different percentiles for NAL have
been used to delimit »high risk« percentiles (i.e.75th,
85th, 90th, and 10th, 15th, 25th). As with AL, partici-
pants are assigned one point for every biomarker in the
»high risk« category. NAL also can be measured »…on
the basis of a summed z score for respondents in which
the score is the total number of standard deviations from
the mean in the direction of high risk for each biomar-
ker…«27:512. Among elderly Taiwanese, no measure of
NAL predicted lifetime stress evaluated as »…widow-
hood, not living with a married son, living alone, and not
participating in groups…«27:509. In contrast, both age and
women’s current stress-levels were positively correlated
with NAL27.
Associations between NAL and stressors also were ex-
amined in a Costa Rican sample. Stressors included
household wealth, economic and health problems early
in life, present economic situation, total monthly income,
cumulative adversity (measured through a questionn-
aire), marital status, participation in church, personal
loss (assessed as loss of a child or widowhood), employ-
ment, malnutrition, and caregiver status33. NAL bio-
markers were analyzed individually and as a cumulative
index33. Being female and advancing age both were asso-
ciated with higher risks for all individual biomarkers and
the NAL index33. However, individually, NAL hormones
did not associate with stressors in a predictable manner.
For example, poor health was linked significantly to
more favorable cortisol values, epinephrine level was not
associated significantly with any stressors, nor was early
childhood adversity correlated with any biomarker33.
The NAL index significantly correlated only with SES,
but correlated positively, although not significantly, with
social deprivation and loss indices33. Similar results oc-
curred regardless of risk quantile examined (10th and
90th percentiles vs. 25th and 75th percentile), whether
or not NAL was tallied as a z-score counting each
biomarkers’ standard deviations from the mean in the di-
rection of high risk, or if NAL was analyzed as a binary
variable33. NAL does not associate significantly with
most stressors, showing significant correlation only with
current stress levels in Taiwanese women and SES in
Costa Rican individuals. Instead of representing long-
-term, cumulative stress, NAL may reflect only more re-
cent stressors.
The best measure of AL is still to be determined, thus
many studies utilize more than one method or unconven-
tional assessments17,18,21,27,33–36,40. Such unconventional
measures include Cacilhas et al.’s evaluating responses
to a Fitness Assessment Short Test and calling it AL to
Kahn and Pearlin’s use of participants’ past diagnoses of
chronic conditions as AL40,43. In general, data published
from 2005–2010 suggest that multiple health outcomes
are associated significantly with AL; these include chro-
nic disease, stress, frailty, mobility, SES, and physical
functioning of bi-polar patients. Several studies report
significant associations only among women, including
correlations with church attendance, PTSD, and self-ap-
praised memory loss.
Cortisol
In addition to cumulative measures of AL, cortisol has
been proposed as a single measure of AL and senescent
decline33,50–53. Cortisol is released in response to stress,
and mediates immune system reactivity, along with glu-
cose, protein, fat metabolism, and cardiovascular reacti-
vity53. Despite being commonly used to assess physiologi-
cal decline, indexes of AL generally are more effective
and significant predictors of outcomes than cortisol
alone28,32,35,54-59.
To ascertain how cortisol associates with mortality
and chronic diseases, serum cortisol (including measures
of total cortisol, corticosteroid-binding globulin (CBG),
and serum free cortisol) and salivary cortisol were as-
sessed in two different cycles of the Longitudinal Aging
Study Amsterdam53. The number of CDCs was assessed
as a count of chronic nonspecific lung disease, diabetes
mellitus, cancer, heart disease, peripheral arterial disea-
se, hypertension, arthritis, and stroke53. No significant
associations were found between serum cortisol and mor-
tality for men or women. In men, higher mortality risk
was associated with the third tertile of salivary morning
cortisol, for women higher mortality risk was associated
with the third tertile of salivary evening cortisol53. No
significant association was reported between cumulative
number of CDCs and cortisol level53. Although not signif-
icant, odds ratios associated with several CDCs increased
with higher levels of cortisol. An index measure of AL
may have been a more effective approach to predicting
mortality and risk of CDCs in this study.
Allostatic load, biological age and biomarkers
Biomarkers are defined as any »biological indicator –
such as blood or saliva – that reflects underlying physio-
logical processes, including both normative processes
and pathogenic states«35:513,60. Biomarkers of senescence
should, alone or in some multivariate composite, predict
functional capability at later ages better than chronologi-
cal age61. Criteria of American Federation for Aging Re-
search suggest biomarkers of senescence should predict
the rate of senescence, monitor basic processes underly-
ing senescence (not disease), must be repeatedly testable
without harm to the subject, and must have an animal
analog61. Accordingly, AL is expected to be a biomarker of
senescence.
Biological age (BA) is a measure expected to estimate
»…the functional status of an individual with reference
to his or her chronological peers on the basis of how well
he or she functions in comparison with others of the same
chronological age…«62:780. BA was developed in hopes of
improving on chronological age in assessing senescen-
ce63. Unfortunately for such methods, assessing BA using
only survivors at any given chronological age considers
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only genetically homogenous individuals who share longe-
vity genes62. Also, large samples of octogenarians or cen-
tenarians are difficult to obtain. Furthermore such sam-
ples suffer from selection bias and selective survival and
in addition, obtaining control samples of individuals who
did not survive is problematic. BA often is estimated as
deviation between actual age and age predicted from
measured biomarkers, but remains closely correlated with
chronological age. Like AL, BA differs between men and
women and should be assessed separately62. Biomarkers
commonly used to estimate biological age include systolic
blood pressure, grip strength, forced expiratory volume,
cholesterol, glucose, and cognitive or neuropsychological
factors, overlapping with AL62,63. Skeletal biomarkers,
scored using the Osteographic Scoring System, also have
been proposed to assess senescence. Initial results using
biological age measured by OSS from Framingham Heart
Study data suggest this measure predicts mortality in
both sexes across age groups62.
Summarizing methods of biological age assessment,
Karasik et al. conclude that in the future, BA estimates
will be useful in directing health interventions61:574. How-
ever, they note, there is no single set of agreed on bio-
markers for determining BA. Nor is it clear how external
factors like sex, ethnicity, and lifestyle contribute to se-
nescence. Caution in using BA to influence policy mat-
ters is advised until techniques are more standardized,
not to mention accurate61. Juster et al. find AL to be a
better predictor of morbidity and mortality than other
measures of biological age63.
Our prevailing health paradigm focuses on treatment
rather than altering causative factors underlying health
and well-being64. Following Koch, Bortz identifies the
traditional health paradigm of interactions between host,
agent, and environment65. However, Bortz argues this
conceptual framework lacks interactions with genes, ex-
ternal agency, internal agency, and aging, concepts that
must now be incorporated into medical models65. Most
chronic degenerative diseases are epigenetic and even
common neurological diseases show low concordance
among twins. External agency encompasses infection, in-
jury, and malignancy, while internal agency focuses on
stress and disuse of physiological systems resulting in AL
and increased morbidity65. Bortz finds the medical field
generally emphasizes external over internal agency and
that the latter may need more attention to improve futu-
re health65. The importance of genes is stressed because
they interact with all other health affecting factors. Depp
et al., like Karasik et al., differentiate between chronolo-
gical aging and biological aging61,66:532. Their primary ex-
ample of a quantitative method for assessing BA is AL.
Depp et al. clearly believe AL is a primary paradigm for
determining BA, citing the successful use of AL to pre-
dict mortality in the MacArthur Study of Successful
Aging cohort66.
Piazza et al. and Johnson et al. reviewed biomarkers
used to assess AL and BA34,60. Piazza et al. differentiate
between two types of stressors, relatively rare stressors
that mark major life events and quotidian stressors, not-
ing that interactions among and accumulation of both
lead to increased morbidity and mortality34. Recent re-
search on the sympathetic-adrenal-medullary axis (SAM),
which is activated in response to immediate threats,
shows that catecholamines are short-lived and released
in a fluctuating daily pattern34. Age-associated changes
in SAM activity are debatable but may include higher
norepinephrine reactivity to stressors, higher average
levels of norepinephrine, and/or reduced basal epinephri-
ne activity34. In addition, chronicity of stress increases
frequency and length of SAM activation, possibly result-
ing in tissue damage34.
The HPA axis, in contrast to the SAM-axis, responds
to longer term stress through release of corticosteroids
such as cortisol, corticotrophin-releasing hormone, adre-
nocorticotropin hormone, and arginine vasopressin34. Re-
search has focused on cortisol because it is easily obtain-
ed and assayed from saliva, has a diurnal rhythm, and is
associated with physiological stress34, 53–58. As HPA reac-
tivity increases with age, the negative feedback loop
controlling the HPA-axis becomes impaired, and aver-
age cortisol may increase or decrease while diurnal fluc-
tuations flatten7,34. Elevated cortisol leads to increased
insulin and in turn may lead to increased abdominal fat
stores7. Prolonged stress appears to depress physiologi-
cal responses to cortisol eventually resulting in cortisol
overproduction, an outcome detrimental to health34.
With age the HPA changes, producing less IGF-1,
growth hormone (GH), and DHEA. Low IGF-1 and GH
are linked to muscle atrophy (sarcopenia) and risk of
breast cancer. Low GH also predicts insulin resistance,
increased adiposity and incidence of cardiovascular dis-
ease, while decreased basal levels of IGF-1, GH, and
DHEA are associated with early mortality in men7.
Such a cascade effect supports the derivation of AL as a
multifactor construct connecting stress to unwanted
outcomes.
AL and the Senescing Soma
Immune system
Around age 40, the immune system begins to decli-
ne34. Phagocytosis becomes less efficient, macrophages
decrease, natural killer cells become less effective, the
thymus shrinks and fewer T cells are formed, while de-
creased production of lymphocytes, and increased pro-
duction of inflammatory biomarkers (e.g. IL-6, tumor ne-
crosis factor-alpha (TNF-a), C-reactive protein (CRP),
and interleukin-1b (IL-1b)) weaken responses to new im-
munologic threats. These changes result in »…concomi-
tant age-related diseases associated with inflammation,
such as osteoporosis, osteoarthritis, and atherosclerosis…«
and perhaps even Alzheimer’s disease34:517,60. Increase of
IL-6, TNF-a, and IL-1b may be related to decreased tes-
tosterone production which predicts mortality in male
veterans and a higher incidence of diabetes and meta-
bolic diseases in women7,60. Links of increased IL-6 and
CRP with sarcopenia vary across samples60.
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Similar to age-related changes, chronic exposure to
stressors decreases lymphocyte concentrations, leading
to weaker vaccine responses, slower wound healing, de-
creased adaptive immunity and loss of natural killer cell
functionality, as well as increases in production of infla-
mmatory biomarkers34. Chronic stress appears to accele-
rate SAM-axis, HPA-axis, and immune system declines.
Stressors appear to have a greater negative effect on
older individuals who tend to have higher cumulative AL
which impedes efficient responses to chronic and rare
life-event stressors34.
Cognitive Decline
Antioxidants such as b-carotene may protect from
cognitive decline in individuals identified as at-risk by
APOE 4 alleles58. Production of reactive oxygen species
(ROS) increases with age, leading to cross-linking of
macromolecules, lipid peroxidation and impaired antioxi-
dant activity7. Among the aged, such oxidative stress can
lead to cognitive decline, loss of autonomy, loss of ability
to perform daily activities, institutionalization, and de-
pressive symptoms7. ROS accelerate tissue damage and
cell aging, especially in cardiac and brain cells7. Healthy
elders show oxidative stress similar to young adults and
show comparable antioxidant defenses, suggesting that
oxidation may not be an inevitable aspect of aging7. Life-
style, including sedentariness, high fat diets, and insuffi-
cient sleep, are linked to oxidative DNA damage, as are
smoking and alcohol use. Associations of stressors with
systemic free radicals appear to be mediated by overpro-
duction of cortisol, insulin, and glucose, and thus linked
to AL7.
Telomere shortening, mtDNA, and telomerase
activity
Telomeres are the protective nucleoprotein structures
capping the ends of eukaryotic chromosomes. Telomeres
shorten during each cell division. This has led to proposals
that telomere attrition is a biomarker of senescence60.
Shortened telomeres are linked to CVD risk factors in-
cluding pulse pressure, obesity, insulin resistance, and
diabetes. They are also associated with excess adiposity,
insulin resistance, and increased leptin levels. Shorter
telomeres predict mortality in non-clinical samples, and
among patients with chronic kidney disease, Alzheimer’s,
and stroke7. Shorter telomere lengths are linked to high-
er ROS levels within cells, perhaps because oxidation de-
creases protein activity and damages telomeric DNA7.
Cross-sectional studies demonstrate individuals with hi-
gher oxidative stress in vivo show shorter telomere len-
gths7. In cell cultures the addition of antioxidants decel-
erates telomere shortening7. Chronic stress may lead to
diminished telomerase activity, subsequent telomere shor-
tening, and a biochemical cascade (including release of
cortisol) resulting in increased disease susceptibility and
early cell senescence. These results support the hypothe-
sis that chronic stress produces a biochemical cascade
that increases AL and the rate of senescence63.
AL, Environments, and Stress
Protective social environments and sociality may me-
diate physiological responses to stress and influence indi-
vidual risk of morbidity and mortality. Among animals’
prosocial behaviors, »…stimulate the release of the neu-
ropeptide oxytocin, which in turn inhibits the stress-in-
duced activity of the HPA-axis, suggesting an inhibitory
influence of oxytocin on stress-responsive neurohormo-
nal systems…«67:S117. Oxytocin injections in rats also led
to decreased blood pressure and cortisol, as well as in-
creased levels of insulin and cholecystokinin, illustrating
how low sociality may increase AL67. Among humans,
higher AL occurs among those with lower SES and asso-
ciates with greater dysregulation of major biological sys-
tems suggesting that social and economic environments
influence stress and its outcomes67.
An adverse environment early in life may produce
physiological responses to stress leading to lower cogniti-
ve abilities and mental health in later life12,69. Luecken
proposes »…a lifespan developmental approach…« pos-
tulating that adverse early family experiences change the
setpoint for physiological stress responses contributing
to the rate of cognitive decline of older adults69:34,72. Both
rodent and human studies suggest prolonged early-life
exposures to glucocorticoids accelerate senescence, cog-
nitive impairments, neuronal damage in the hippocam-
pus, and (for humans) poorer performance on hippocam-
pus-driven cognitive tasks69–71. Dysregulation of the car-
diovascular system also associates with cognitive decline
in adulthood, supporting the AL model that suggests as-
sessing dysregulation across multiple systems is necessary
for understanding senescent decline69.
The brain is a target of stress. Specifically, the hippo-
campus, amygdala, hypothalamus, and prefrontal cortex
change in response to chronic stress72. Alterations in brain
physiology primarily result from release of stress-respon-
sive glucocorticoids. Loizzo differentiated two components
of AL: allostatic lift (cognitive enrichment), and allostatic
drag (aversive effects linked to stress)73. Increasing allo-
static lift through medication and psychotherapy may miti-
gate effects of allostatic drag by »…minimizing wear-and-
-tear and optimizing plasticity and learning…«34:186.
Statistical modeling of allostatic load
Due to problems inherent in longitudinal data on ag-
ing, several research groups targeted modeling techni-
ques to improve empirical measures of AL18,74–76. Yashin
et al. addressed the lack of a mathematical framework of
AL that would account for physiological changes due to
aging, stress, adaptive capacity, and environmental dif-
ferences, ultimately suggesting a stochastic process mo-
del74–75. They note that unobserved factors generate
»…hidden variability to susceptibility to diseases and
death in populations…«75:1. They propose a model ac-
counting for hidden heterogeneity in measures of AL,
stress, and age-dependent physiological changes to im-
prove longitudinal data analyses. Arbeev et al. focused on
models incorporating missing data sets and improving
genetic models of aging, health, and longevity76.
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Discussion
Biological anthropology and human biology have long
term interests in assessing life styles, stress and physio-
logical responses as predictors of morbidity, disability
and mortality among elders. Although AL does not mea-
sure the dynamic nature of allostasis or interindividual
variation, it does assess within individual loss of function
and variation when measured over time3–5,9,10,14–18. AL es-
timates losses in physiological function due to stress-re-
lated responses across multiple domains: cardiovascular,
metabolic, endocrine and energy storage3. Allostasis is an
intraindividual process whereby internal systems reset
in response to changing environmental, somatic, or men-
tal conditions4. AL is associated significantly with future
morbidity, disability, mortality, physical and cognitive
function among elders, morbidity among Samoans of the
South Pacific, days of school missed by children and var-
ies across elderly Japanese living more traditional versus
more modern life styles7–9,12–18. Results from case studies
reviewed in this article suggest that index measures of
AL also correlate with morbidity in South Pacific island-
ers, cognitive disorders, level of physical activity, socio-
economic status, post-traumatic stress syndrome, de-
pression and social support in the form of church
attendance. AL correlates better with these variables
than do individual biomarkers such as cortisol. Summa-
ries of reviews covering additional aspects of AL, includ-
ing advances in biomarker research, how senescence af-
fects the soma, and progress in statistical modeling
applicable to AL, provide a broader understanding of the
paradigm.
Theoretically, allostatic load assesses somatic wear
and tear experienced over time as the body continuously
adapts to changing environments and situations. Since
its inception, AL has become increasingly popular for
measuring the effects of senescence on the human body
and mind10. From 2005–2010, 47 articles indexed in the
ISI database included both »allostatic load« and »aging«
as key words. Of these, 44 specifically examined AL in
humans. Among these were 27 case studies, 13 reviews,
and 4 articles pertaining to mathematical modeling. Case
studies primarily were epidemiological and cross-sectional,
although several prospective and retrospective cohort
studies were also published. Cross-sectional studies like-
ly are most prevalent because of their ease to effectuate
and low costs. However, unlike retrospective and pros-
pective cohort studies, cross-sectional studies cannot es-
tablish causality.
Several clear themes emerged from the fourteen re-
views of AL published between 2005 and 2010. First
many questioned proposed qualitative and quantitative
measures of age and/or the efficacy of age-related bio-
markers used in such models. Two also broached ques-
tions of future health policies concluding that AL will im-
pact how health policy is formulated in the future,
although current applications are not yet definitive. A
second group focused on relationships among AL, health,
and environmental variation (e.g. SES, stress, or protec-
tive social environments), while the final group address-
ed cognitive performance and AL.
Case studies of AL utilized a broad array of physiolog-
ical biomarkers. However, the majority focused on the
ten biomarkers originally proposed by Seeman et al. and
McEwen or these ten plus additional biomarkers10,20.
Other studies utilized NAL biomarkers or focused solely
on cortisol. Two studies suggested they were examining
allostatic load, but used only nontraditional measures in
their evaluations39,42. Results from case studies support
previous findings suggesting AL is a predictor of morbid-
ity, mortality, and chronic degenerative diseases. In addi-
tion, chronic stress, PTSD, self-appraised memory and
socioeconomic status are now reliably linked to differen-
tials in AL. In some cases, positive associations were ob-
served only in women while the opposite was never true.
Only two studies failed to report an association between
AL and SES, both in Taiwanese populations. Perhaps dif-
ferent biomarkers or thresholds are needed to evaluate
AL in Taiwanese and other non-Western/European popu-
lations, or the model may not fit some cultural settings.
Several reviews examined the usefulness of AL and
biomarkers for determining BA, senescent decline, and
cognitive performance. Those focusing on policy agreed
there is no agreement as to a definitive measure of AL
and therefore currently no way to incorporate this para-
digm into public health planning or policy. Reviews re-
garding health differences and variable environments re-
inforced findings that physical and mental stressors as
well as lower SES can lead to higher AL, higher morbid-
ity, and higher mortality. Only three papers focused on
problems inherent in longitudinal studies, reflecting the
paucity of longitudinal studies concerning AL.
Future Directions
Over the coming decades, we can expect the older pop-
ulation to continue to expand as age-specific mortality
rates continue their current worldwide decline. This
transition suggests that understanding physiological res-
ponses of elders to stress and chronic degenerative condi-
tions will become increasingly important. Currently, one
of the most promising paradigms for studying senescent
change is allostatic load. Research published 2005–2010
indicates that AL provides a viable model for assessing
physiological dysfunction. Across a broad array of re-
search areas, recent results show that AL is a useful mea-
sure of cumulative somatic stress and a relatively more
accurate predictor of senescent decline, morbidity, and
mortality than other current methods.
In addition to assessing senescence, we propose that
allostatic load will aid in assessing historical trauma
among American Indians, African Americans and others,
in elucidating the male-female morbidity-mortality para-
dox, assessing clinical, diagnostic and monitoring of geri-
atric patients and residents in nursing home and ambu-
latory care settings, and understanding problems in child
growth and development. Historical trauma includes the
lasting effects of post-traumatic stress disorder in survi-
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vors of catastrophic events and their descendants (e.g.
children, grandchildren, etc.). Transgenerational incre-
ases in mental and physical illnesses, post-traumatic
stress disorder, obesity, diabetes, hypertension, and car-
diovascular disease have been observed in multiple popu-
lations, including Native Americans from the European
invasion, African Americans following slavery and segre-
gation, European Jews who suffered the Holocaust, the
Japanese who have been the sole victims of atomic war-
fare, and multiple groups such as Somalis, Tutsi, and
Croatians who experienced brutality and torture by their
neighbors and countrymen. In such cases, every age
group and both sexes of survivors collectively endured a
common thread of trauma. In the past, researchers have
had a difficult time quantifying historical trauma in epi-
demiological research as historical trauma is a life-long
population-level stressor. Historical trauma results from
unresolved grief and loss passed across multiple genera-
tions and lifetimes by the original sufferers to their prog-
eny. AL may provide a quantitative assessment for mea-
suring physiological loses caused by historical trauma in
survivors and their descendants.
Across populations and in data from multiple longitu-
dinal epidemiological studies men self-report fewer health
problems than do women, however these same men die
at a faster rate than women. This has become known as
the male-female morbidity-mortality paradox and has not
been resolved using standard epidemiological designs71,77–79.
Applications of AL likely will aid in resolving this para-
dox as it is an objective (as opposed to subjective) assess-
ment of current function and health that may be juxtapo-
sed with self-reports and clinical assessments of health.
AL is likely to aid this research, for example AL is signifi-
cantly higher among elderly men than women in both
Samoan and Japanese samples, although in both cases
men report better health than do women80,81. Similarly,
as mentioned earlier, women were less likely to die dur-
ing follow-up than were men with the same AL at base-
line in the McArthur Study Cohort36. Another interest-
ing finding is that some associations are observed only
among women, for example of AL with church atten-
dance, PTSD and self-reported memory losses.
AL also may be useful as an adjunct to the standard
clinical examination. Standard clinical protocols assess
multiple risk factors (e.g. blood pressure, glucose, lipids,
etc.) as single, independent contributors to risks. How-
ever, AL combines multiple such risk factors from multi-
ple domains into a single clinical measure that assesses
overall somatic condition. AL may then be monitored for
change over time and for evaluating responses to treat-
ment protocols. This information is likely to improve pa-
tient compliance with prescribed treatments, be useful in
monitoring improvements and loses of health status over
time, and assessing improvements or declines in patient
health over time serving as a basis to alter treatments.
Ongoing monitoring of AL may improve all individuals’
physiological well-being. Using AL, doctors can monitor
patients to reduce and delay onset of chronic degenera-
tive diseases and improve capacity to complete activities
of daily living. AL has »…prospectively predicted clini-
cally relevant outcomes including incident cardiovascu-
lar events, physical function, cognitive decline and mor-
tality. Such findings provide evidence that AL captures
physiological changes preceding the occurrence of clini-
cal disease and, hence that AL represents a meaningful
step in the disease development process…«48:465. Addi-
tionally, results show depression positively correlates
with higher rates of senescence suggesting physicians
pay closer attention to current and past depression as a
»…marker for physical health decline even when there
has been a sustained full remission of depressive symp-
toms«45:450. Furthermore, improving AL reduces risk of
morbidity and mortality, and risk factor change plays an
important role in mortality even among high-functioning
elderly36.
No reports yet show that AL is being utilized in clini-
cal settings. As biomarkers to evaluate AL are standard
in clinical practice, AL should be used as a diagnostic tool
for assessing senescent decline. Because numerous stud-
ies demonstrate the strong association between AL and
chronic stressors, moving AL from passive laboratory
settings to clinical applications should be a major future
goal. Finally, AL likely will be useful for examining child
growth and development. AL already is known to be as-
sociated with illness and days of school missed by chil-
dren. It also is clear that stress is associated with
telomere length in both children and adults. Higher AL
likely is associated with growth failure and slow matura-
tion of children, such as sub-standard attained height.
Thus, unexplained instances of subpar child growth may
be directly evaluated by assessments of AL.
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FIZIOLO[KA DISREGULACIJA I SOMATSKI PAD ME\U STARIJOM POPULACIJOM:
MODELIRANJE, PRIMJENA I REINTERPRETACIJA ALOSTATSKOG OPTERE]ENJA
S A @ E T A K
Stope smrtnosti nastavljaju se smanjivati me|u post-reproduktivnim pojedincima. To ~ini sve va`nijim razumije-
vanje dugoro~ne fiziolo{ke reakcije na stres. Alostatsko optere}enje (AL) razvijeno je kako bi procijenilo {tetne u~inke
somatskog odgovora na vi{e stresora tijekom `ivota. AL proizlazi iz razvojnih iskustava, genetskih predispozicija, oko-
li{a, psihosocijalnog i `ivotnog na~ina `ivota te drugih izvora stresa. U ranim `ivotnim stadijima sustav stresa inicira
proizvodnju hormona koji odr`avaju kontinuirani alostatski odgovor organizma. Kasnije u `ivotu, sustav dizajniran za
ubla`avanje stresa mo`e uspjeti ili biti ugro`en, izazivaju}i ne`eljene somatske promjene i disregulacije. To stavlja
optere}enje na regulatorni sustav koji ovisi o dnevnoj bazi odgovora na stres, stvaraju}i predispoziciju za stani~na
o{te}enja i degenerativne bolesti. U ovom radu donosimo 44 publikacije od 2005. do 2010. godine istra`uju}i povezanost
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izme|u AL i faktora rizika, kroni~nih bolesti, morbiditeta i mortaliteta u starijih osoba. Zbroj rezultata sugeriraju da
AL utje~e na aspekte fiziolo{ke disregulacije i somatski pad, predvi|a {tetni pad s obzirom na godine, i povezan je s
negativnim sociokulturnim atributima i psiholo{kim rezultatima. Takvi konzistentni rezultati i {iroka primjena AL,
dok se jo{ uvijek modelira i ponovno interpretirati, ukazuju na njegovu korisnost kod istra`ivanja i kao klini~ki alat. AL
pru`a mogu}nost biomarkiranja starenja, a procjenjivanje tijekom `ivotnog vijeka }e pomo}i u predvi|anju budu}ih
negativnih zdravstvenih ishoda.
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